BEVERLY, MA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)CONGENITAL HEART SURGEONS' SOCIETY, founded in 2003, is a small nonprofit in the Diseases & Disorders sector that reported $936K in total revenue in fiscal year 2024. Revenue decreased 10% compared to the prior year. Expenses of $870K left a modest 7% surplus.
TO ASSOCIATE PERSONS INTERESTED IN, AND CARRY ON ACTIVITIES RELATED TO, THE SCIENCE AND PRACTICE OF CONGENITAL HEART SURGERY, TO SPONSOR AND OVERSEE MULTI-INSTITUTIONAL CLINICAL STUDIES EVALUATING THE APPLICATION OF SURGICAL INTERVENTIONS IN CONGENITAL HEART DISEASE, TO ENCOURAGE AND STIMULATE INVESTIGATION AND STUDY THAT WILL INCREASE THE KNOWLEDGE OF CONGENITAL CARDIAC PHYSIOLOGY, PATHOLOGY AND THERAPY, AND TO CORRELATE AND DISSEMINATE SUCH KNOWLEDGE, TO HOLD SCIENTIFIC MEETINGS FEATURING FREE DISCUSSION OF PROBLEMS AND DEVELOPMENTS RELATING TO CONGENITAL HEART SURGERY, AND TO SUCCEED TO, AND CONTINUE TO CARRY ON THE ACTIVITIES FORMERLY CONDUCTED BY THE CONGENITAL HEART SURGEONS SOCIETY, AN UNINCORPORATED ASSOCIATION.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $935,575 | $1,040,934 | -0.1% |
| Expenses | $869,830 | $1,004,439 | -0.1% |
| Net Income | $65,745 | $36,495 | +0.8% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| ROBERT D JACQUISS MD | PRESIDENT/VICE PRESIDENT | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| JENNIFER C ROMANO MD | VICE PRESIDENT/SEC-TREASURER | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| GLEN VAN ARSDELL MD | SEC-TREASURER/DIRECTOR | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| DAVID M OVERMAN MD | IMMEDIATE PAST PRESIDENT | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| CHRISTOPHER A CALDRONE FRCS MD | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| BAHAALDIN ALSOUFI MD | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| LUCA A VRICELLA MD | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| EMILE A BACHA MD | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| CHARLES D FRASER MD | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| CARLOS M MERY MD | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| JAMES E O'BRIEN JR MD | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| STEPHANIE FULLER MD | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| MARSHALL L JACOBS MD | HISTORIAN | 2.00 |
Director
|
$0 | $0 | $0 |
| CARL L BECKER MD | EDITOR/DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| JOSEPH A DEARANI MD | PAST PRESIDENT (10/24) | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| JAMES K KIRKLIN MD | DIRECTOR (10/24) | 2.00 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | $935,575 | $869,830 | $1,132,013 | $65,745 |
| 2023 | $1,040,934 | $1,004,439 | $948,019 | $36,495 |
| 2022 | $771,594 | $771,899 | $876,101 | $-305 |
| 2021 | $847,267 | $836,133 | $1,054,429 | $11,134 |
| 2020 | $793,088 | $784,421 | $959,114 | $8,667 |
| 2019 | $975,823 | $967,794 | $889,858 | $8,029 |
| 2018 | $798,818 | $771,576 | $797,727 | $27,242 |
Compare CONGENITAL HEART SURGEONS' SOCIETY with other nonprofits in Massachusetts and across the country.